View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
March 1, 2022

Zsquare raises funding to launch single-use ENT endoscope

Zsquare plans to use the funds to accelerate R&D for expanding the potential use of its ENT product to other indications.

Zsquare has raised $15m in a financing round led by private equity firm Chartered Group to introduce its single-use ear, nose and throat (ENT) endoscope.

Free Report
img

What’s missing from your IPO industry assessment?

IPO activity all but stopped in 2020, as the investment community grew wary of the effects of COVID-19 on economies. No matter how deserving a business was of flotation, momentum was halted by concerns of when a ‘new normal’ of working patterns and trade would set in. Recently, sentiment has changed. Flotations picked up again during the second half of 2021, and now in 2022 the mood is decidedly optimistic. Business leaders have their eyes on fast rebounding economies, buoyant market indices and the opportunity once again to take their businesses public. As a result, global IPOs are expected to hit back this year. With GlobalData’s new whitepaper, ‘IPOs in Consumer and Retail: 5 must-include elements for your prospectus industry report’, you can explore exactly what is needed in the essential literature. GlobalData’s focus lies in the critical areas to get right:
  • Macroeconomic and demographic environment
  • Consumer context
  • Industry environment
  • Competitive environment
  • Route to market
Interested to learn more about what to include in your IPO Industry Assessment report? Download our free whitepaper.
by GlobalData
Enter your details here to receive your free Report.

The company plans to launch the disruptive ENT endoscope after receipt of its US Food and Drug Administration (FDA) clearance, which is anticipated to be obtained in the third quarter of the year.

Additionally, Zsquare intends to use the funds to accelerate research and development (R&D) for expanding the potential use of its ENT product to other indications.

Zsquare CEO and co-founder Asaf Shahmoon said: “As the world is rapidly moving towards single-use devices, Zsquare is advancing to introduce new groundbreaking technologies and capabilities to this up-and-coming market.

“This round will help the company advance our go-to-market plan for the initial ENT product, as well as ramp up R&D for next-generation capabilities and further indications.”

The company’s single-use endoscopic platform is intended to improve diagnostic performance while eliminating the risk of cross-infection and reducing healthcare costs.

The platform’s hybrid design includes a reusable imaging core and alternating, indication-specific disposable shells.

This helps to address several indications and solve unmet imaging requirements for new indications.

Zsquare stated that the design of the platform helps to overcome the inherent diameter versus image quality trade-off of conventional chip-on-the-tip designs, in a cost-effective manner.

The ENT endoscope features cost-effective optics in a single-use shell, as well as imaging electronics in a detachable, reusable imaging core.

This reduces the diameter of the optical component without compromising on image resolution.

Furthermore, the solution enables access to anatomies and eliminates the risk of cross-contamination.

Related Companies

Free Report
img

What’s missing from your IPO industry assessment?

IPO activity all but stopped in 2020, as the investment community grew wary of the effects of COVID-19 on economies. No matter how deserving a business was of flotation, momentum was halted by concerns of when a ‘new normal’ of working patterns and trade would set in. Recently, sentiment has changed. Flotations picked up again during the second half of 2021, and now in 2022 the mood is decidedly optimistic. Business leaders have their eyes on fast rebounding economies, buoyant market indices and the opportunity once again to take their businesses public. As a result, global IPOs are expected to hit back this year. With GlobalData’s new whitepaper, ‘IPOs in Consumer and Retail: 5 must-include elements for your prospectus industry report’, you can explore exactly what is needed in the essential literature. GlobalData’s focus lies in the critical areas to get right:
  • Macroeconomic and demographic environment
  • Consumer context
  • Industry environment
  • Competitive environment
  • Route to market
Interested to learn more about what to include in your IPO Industry Assessment report? Download our free whitepaper.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network